Akèy › Sindrom Sjogren › Massachusetts
Etid klinik pou Sindrom Sjogren nan Massachusetts
5 etid pou Sindrom Sjogren ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Tufts Medical Center, Boston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07621809Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Tufts Medical Center, Boston
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 27, 2026 · NCT07404865A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Tufts University School of Dental Medicine, Boston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT06747949The Myelin Disorders Biorepository Project
- Massachusetts General Hospital (MGH), Boston
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 23, 2025 · NCT03047369Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.